Login
   

e/Autologous patient specific tumor antigen response

New Query

Information
has glosseng: Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and for comparative oncology.
lexicalizationeng: Autologous patient specific tumor antigen response
instance ofc/Cancer treatments

Query

Word: (case sensitive)
Language: (ISO 639-3 code, e.g. "eng" for English)

Lexvo © 2008-2025 Gerard de Melo.   Contact   Legal Information / Imprint